Overall, these studies identified Tmp as a MexXY-OprM substrate and the potential for MexXY-OprM to contribute to Caz and Imi resistance when overexpressed, a phenomenon typically observed in CF clinical isolates (24, 25). Here, OPRM1 is linked to cystic fibrosis.